Triple

T1347021
Position Surface form Disambiguated ID Type / Status
Subject John Scott Medal E28593 entity
Predicate notableRecipient P108 FINISHED
Object Drew Weissman
Drew Weissman is an American physician-scientist best known for his pioneering work on mRNA technology that enabled the development of COVID-19 vaccines.
E157144 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Drew Weissman | Statement: [John Scott Medal, notableRecipient, Drew Weissman]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Drew Weissman
Context triple: [John Scott Medal, notableRecipient, Drew Weissman]
  • A. Katalin Karikó
    Katalin Karikó is a Hungarian-American biochemist whose pioneering work on mRNA technology enabled the development of several COVID-19 vaccines and earned her a share of the 2023 Nobel Prize in Physiology or Medicine.
  • B. Peter C. Doherty
    Peter C. Doherty is an Australian immunologist and Nobel Prize laureate renowned for his groundbreaking work on how the immune system recognizes virus-infected cells.
  • C. Harold Varmus
    Harold Varmus is a Nobel Prize–winning American cancer researcher and former director of the National Institutes of Health and the National Cancer Institute.
  • D. Jules Hoffmann
    Jules Hoffmann is a Luxembourg-born French immunologist and Nobel Prize laureate renowned for his pioneering work on the innate immune system, particularly in insects.
  • E. Stuart L. Schreiber
    Stuart L. Schreiber is an influential American chemist renowned for pioneering work in chemical biology and diversity-oriented synthesis, which has profoundly impacted drug discovery and biological research.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Drew Weissman
Triple: [John Scott Medal, notableRecipient, Drew Weissman]
Generated description
Drew Weissman is an American physician-scientist best known for his pioneering work on mRNA technology that enabled the development of COVID-19 vaccines.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Drew Weissman
Target entity description: Drew Weissman is an American physician-scientist best known for his pioneering work on mRNA technology that enabled the development of COVID-19 vaccines.
  • A. Katalin Karikó
    Katalin Karikó is a Hungarian-American biochemist whose pioneering work on mRNA technology enabled the development of several COVID-19 vaccines and earned her a share of the 2023 Nobel Prize in Physiology or Medicine.
  • B. Peter C. Doherty
    Peter C. Doherty is an Australian immunologist and Nobel Prize laureate renowned for his groundbreaking work on how the immune system recognizes virus-infected cells.
  • C. Harold Varmus
    Harold Varmus is a Nobel Prize–winning American cancer researcher and former director of the National Institutes of Health and the National Cancer Institute.
  • D. Jules Hoffmann
    Jules Hoffmann is a Luxembourg-born French immunologist and Nobel Prize laureate renowned for his pioneering work on the innate immune system, particularly in insects.
  • E. Stuart L. Schreiber
    Stuart L. Schreiber is an influential American chemist renowned for pioneering work in chemical biology and diversity-oriented synthesis, which has profoundly impacted drug discovery and biological research.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a49854eb3481908c7d56b2e449a290 completed March 1, 2026, 7:49 p.m.
NER Named-entity recognition batch_69a4c2406c488190b2c04d54d9c5e94c completed March 1, 2026, 10:48 p.m.
NED1 Entity disambiguation (via context triple) batch_69acce68225081909d995cd7ae5f2224 completed March 8, 2026, 1:18 a.m.
NEDg Description generation batch_69acd25243448190b147b9eb9293f925 completed March 8, 2026, 1:35 a.m.
NED2 Entity disambiguation (via description) batch_69acd2c474908190a9e9b74addcb1c9a completed March 8, 2026, 1:37 a.m.
Created at: March 1, 2026, 7:56 p.m.